https://www.selleckchem.com/pr....oducts/baxdrostat.ht
Chronic rhinosinusitis (CRS) occurs in 10% of the adult population in Europe and the USA and can be differentiated into CRS without nasal polyps and CRS with nasal polyps (CRSwNP). Both phenotypes are characterized by a high disease burden and an overlapping spectrum of symptoms, with facial pain and loss of smell being the most differentiating. Great progress has been made in the understanding of CRS pathophysiology from the epithelium and epithelial-mesenchymal transition to innate and adaptive immunity pathways and, finally, o
Like
Comment
Share
